Leveraging on the availability of clinical data of subjects with anti-MDA5 antibodies that included information on COVID-19 infection and/or vaccination to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the authors performed a retrospective observational study investigating the association between COVID-19 and anti-MDA5-positive DM. This evidence concerns the gene IFIH1 and COVID-19.